426
P. Comba et al. / Inorganica Chimica Acta 374 (2011) 422–428
ature, pyridin-2-aldehyd (12.2 g, 11.4 mmol) and acetondicarboxy-
late–dimethylester (19.8 g, 11.4 mmol) were added and the pH
was adjusted to 4 by Na2CO3. After stirring at ambient conditions
for 1 week, the pH was adjusted to 9 (Na2CO3), and the solution
was extracted with CH2Cl2 (five times). The combined CH2Cl2 frac-
tion was dried over MgSO4 and evaporated to dryness. The oily res-
idue was washed with diethylether and dissolved in MeOH
(80 ml); H2O (10 ml) was added under stirring. At 4 °C, a white so-
lid crystallized and was removed by filtration, washed with EtOH/
H2O 1:1 and dried in vacuum. Yield: 3.3 g (1 mmol; 9%), white so-
lid. Anal. Calc. for C17H20N2O5: C, 61.44; H, 6.07; N, 8.43. Found: C,
61.37; H, 6.04; N, 8.42%. 1H NMR (200 MHz, CDCl3): d = 1.94 (m,
3H, CH–CH2–CH2); 2.30 (m, 2H, N–CH2–CH2); 2.81 (td,
3J = 2.72 Hz, 3J = 8.6 Hz, 1H, N–CH–CH2); 3.18 (m, 1H, N–CH2–
CH2); 3.74 (s, 3H, O–CH3); 3.86 (d, 3J = 11.2 Hz, 1H, CO–CH–CO);
3.97 (s, 3H, O–CH3); 4.19 (d, 3J = 10.7 Hz, 1H, CO–CH–CO); 4.50
(d, 3J = 11.04 Hz, 1H, N–CH–Py); 7.45 (m, 2H, HAr); 7.86 (td,
3J = 7.6 Hz, 4J = 1.77 Hz, 1H, HAr); 8.86 (d, 3J = 5.53 Hz, 1H, HAr).
13C NMR (50 MHz, CDCl3): d = 21.75 (1C, N–CH2–CH2À); 30.15
(1C, CH–CH2–CH2À); 51.13 (1C, N–CH2–CH2À); 52.41 (1C, O–CH3);
52.54 (1C, O–CH3); 61.51 (1C, CO–CH–CO); 62.68 (1C, N–CH–Py);
67.10 (1C, CO–CH–CO); 69.10 (1C, N–CH–CH2); 123.67, 124.53,
137.09, 150.63, 157.67 (5C, C-arom.); 170.5 (1C, COOCH3); 171.80
(1C, COOCH3); 199.82 (1C, C@O). MS: FAB C17H20N2O5,
[M+H]+ = 333.1.
1.55–2.15 (m, 10H, CH2); 2.91 (q, 3J = 8.2 Hz, 2H); 3.10 (m, 2H);
3.43 (t, 3J = 10.9 Hz, 2H); 3.59 (dd, 4J = 2.7 Hz, 3J = 11.0 Hz, 2H);
3.69 (s, 3H, –OCH3); 3.71 (s, 3H, –OCH3); 3.75 (s, 3H, –OCH3);
3.78 (s, 3H, –OCH3); 4.04 (d, 3J = 11.5 Hz, 2H); 4.10 (d,
3J = 11.7 Hz, 2H); 4.19 (d, 3J = 4.1 Hz, 2H); 7.15–7.70 (m, 12H,
HAr); 8.50–8.60 (m, 4H, HAr). 13C NMR (50 MHz, CDCl3): d = 17.42,
17.50, 21.37, 25.90, 30.90, 50.50, 50.57, 51.15, 51.79, 52.22,
52.30, 52.34, 52.45, 53.78, 54.46, 62.52, 62.68, 63.19, 64.77,
64.82, 68.63, 68.78, 72.01, 72.05, 121.90, 121.94, 122.34, 122.50,
122.93, 122.97, 124.59, 124.68, 136.04, 136.11, 136.22, 148.35,
149.32, 149.34, 156.81, 156.83, 163.47, 163.50, 169.67, 169.88,
170.20, 170.26, 202.59, 202.63, 206.92. MS: FAB C26H30N4O5
D
[M+H]+ = 479.3. [
a]
20 = 36.3° (R, rac) (c = 1 in CHCl3).
3.2.4. L3 (S,rac)-9-Oxo-2-(pyridin2-yl)-7-(phenyl(pyridin-2yl)-
methyl)-3,7-diazatricyclo[3.3.33,4.1]-dodecan-1,5-
dicarbonsäuredimethylester
7-Oxo-5-(pyridinyl-2yl)octahydroindolizine-6,8-dicarboxylate-
dimethylester (900 mg, 2.7 mmol), suspended in EtOH (10 ml) was
cooled to 0 °C. (S)-phenyl(pyridin-2-yl)methylamine (500 mg,
2.7 mmol) were added dropwise, stirred for 30 min and formalde-
hyde (0.5 ml, 6 mmol, 37% in H2O) were added. After 24 h at ambi-
ent temperature, the solvent was removed in vacuum, the residue
dissolved in little CH2Cl2 and dried over MgSO4. The solution was
evaporated to dryness and the residue crystallized from EtOH/
Et2O. Yield: 660 mg (1.2 mmol, 32%), white solid (1:1 mixture of
[S,S], [S,R] diastereomers). X-ray structure (co_SEW 20). Anal. Calc.
for C31H32N4O5: C, 65.87; H, 5.97; N, 10.36. Found: C, 65.32; H,
6.00; N, 10.14%. 1H NMR (200 MHz, CDCl3): d = 1.40–2.10 (m,
10H, CH2); 2.82 (m, 2H); 3.02 (m, 2H); 3.23 (d, 3J = 10.9 Hz, 1H);
3.35 (d, 3J = 11.1 Hz, 1H); 3.45–3.60 (m, 2H); 3.63, 3.64, 3.72,
3.73 (s, 12H, –OCH3); 3.99 (d, 3J = 10.8 Hz, 2H); 4.10 (d,
3J = 8.9 Hz, 2H); 4.65 (s, 2H, py–CH–N); 7.75–7.95 (m, 22H, HAr);
8.30–8.50 (m, 4H, HAr). 13C NMR (50 MHz, CDCl3): d = 21.42,
25.94, 50.34, 52.20, 52.34, 53.68, 54.19, 54.61, 62.72, 63.46,
68.97, 71.87, 122.18, 122.98, 124.75, 125.10, 127.56, 128.32,
3.2.2. L1 (9-Oxo-2-(pyridin2-yl)-7-(pyridin-2yl-methyl)-3,7-
diazatricyclo[3.3.33,4.1]dodecan-1,5-dicarbonsäuredimethylester)
7-Oxo-5-(pyridinyl-2yl)octahydroindolizine-6,8-dicarboxylate-
dimethylester (4.6 g, 13.8 mmol) were suspended in EtOH (35 ml)
and cooled to 0 °C. 2-Aminomethylpyridin (1.6 g, 14.7 mmol) were
added dropwise, and the solution was left stirring for 30 min be-
fore formaldehyde (2.7 ml, 32.4 mmol, 37% in H2O) was added.
After 24 h stirring at ambient temperature, the solution was evap-
orated to dryness in vacuum, dissolved in (CH2Cl2, 50 ml) and dried
over MgSO4. This solution was evaporated to dryness and the res-
idue was recrystallized from EtOH/Et2O. Yield: 2.8 g (6.0 mmol,
43.5%), white solid. X-ray structure of the racemic ligand (co_SEW
4a). Anal. Calc. for C25H28N4O5: C, 64.64; H, 6.08; N, 12.06. Found: C,
64.22; H, 6.08; N, 11.89%. 1H NMR (200 MHz, CDCl3): d = 1.70–2.35
(m, 4H, CH–CH2–CH2); 3.18 (td, 2J = 15.2 Hz, 3J = 8.4 Hz, 2H, N–
CH2); 3.60–3.85 (m, 3H); 3.88 (s, 3H, OCH3); 3.97 (s, 3H, OCH3);
4.04 (s, 2H, Py–CH2); 4.36 (s, 1H, Py–CH–N); 7.25–7.90 (m, 6H,
128.45, 136.09, 136.58, 140.89, 148.69, 149.40, 156.66, 169.74,
D
170.27. MS: FAB C31H32N4O5 [M+H]+ = 541.4. [
(c = 1 in CHCl3).
a]
20 = 5.4° (S,rac)
3.2.5. (rac)-[(L1)Cu(OTf)]OTfÃH2O
L1 (400 mg, 0.86 mmol) und Cu(OTf)2 (312 mg, 0.86 mmol) in
MeCN (water-free, 10 ml) were stirred under Ar for 6 h. The blue
solution was reduced to approx. 5 ml (vacuum), and Et2O (10 ml)
was slowly diffused into this solution. The resulting blue solid
was collected and crystallized from MeCN/Et2O. Yield: 350 mg
(0.4 mmol, 47%), blue solid. Anal. Calc. for C27H30CuF6N4O12S2: C,
38.41; H, 3.58; N, 6.64. Found: C, 38.27; H, 3.69; N, 6.72%. MS:
FAB C27H30CuF6N4O12S2, [(L7)Cu(OTf)]+ = 677.1 (calc.: 677.1).
H
Ar); 8.69 (d, 3J = 4.8 Hz, HAr); 8.74 (d, 3J = 4.8 Hz, HAr). 13C NMR
(50 MHz, CDCl3): d = 21.37 (1C, N–CH2–CH2À); 25.86 (1C, CH–
CH2–CH2À); 50.47 (1C, N–CH2–CH2À); 52.41, 52.24 (2C, O–CH3);
55.24, 56.00 (2C, N–CH–Cq); 62.43, 63.06 (2C, Cq); 62.74 (1C, N–
CH2–Py); 121.90, 122.74, 122.91, 124.61, 136.03, 136.27, 148.62,
149.25, 156.70, 158.72 (10C, CAr); 169.55, 170.00 (2C, –OCH3);
202.59 (1C, C@O). MS: FAB C25H28N4O5 [M+H]+ = 465.2.
3.2.6. (R,rac)-[(L2)Cu(OTf)]OTfÃH2OÃMeOH
3.2.3. L2 (R,rac)-9-oxo-2-(pyridin2-yl)-7-(1-(pyridin-2yl)-ethyl)-3,7-
diazatricyclo[3.3.33,4.1]dodecan-1,5-dicarbonsäuredimethylester
7-Oxo-5-(pyridinyl-2yl)octahydroindolizin-6,8-dicarboxylate-
dimethylester (2.5 g, 7.5 mmol), suspended in MeOH (60 ml) was
cooled to 0 °C. (R)-1-(pyridinyl-2yl)ethylamine (0.92 g, 7.5 mmol)
was added dropwise and stirred for 30 min. Formaldehyde
(1.8 ml, 15 mmol, 37% in H2O) was added and, after stirring at
ambient temperature for 24 h, the solution was evaporated to dry-
ness in vacuum, dissolved with the minimum amount of CH2Cl2
and dried over MgSO4. The solution was evaporated to dryness
and the residue crystallized from EtOH/Et2O. Yield: 1.8 g
(3.7 mmol, 50%), white solid (1:1 mixture of [R,S], [R,R] diastereo-
mers). X-ray structure (co_SEW 17a). Anal. Calc. for C26H30N4O5: C,
65.26; H, 6.32; N, 11.71. Found: C, 65.28; H, 6.35; N, 11.68%. 1H
NMR (400 MHz, CDCl3): d = 1.47 (t, 3J = 6.7 Hz, 6H, CH–CH3);
(R,rac)-L2 (200 mg, 0.4 mmol) and Cu(OTf)2 (137 mg, 0.4 mmol)
in MeOH (water-free, 5 ml) were stirred under Ar at ambient tem-
perature for 6 h. The blue solution was reduced to approx. 2 ml
(vacuum), and Et2O (5 ml) was slowly diffused into this solution.
The resulting blue solid was collected and crystallized from
MeOH/Et2O. Yield: 170 mg (0.19 mmol, 48%), green solid. Anal.
Calc. for C29H36CuF6N4O13S2: C, 39.12; H, 4.08; N, 6.29. Found: C,
39.54; H, 4.32; N, 6.36%. MS: FAB
C29H36CuF6N4O13S2,
[(L7)Cu(OTf)]+ = 691.2 (calc.: 691.2); [(L7)Cu(OTf)](H2O)+ = 709.3
(calc.: 709.2); [(L7)Cu(OTf)](MeOH)+ = 723.2 (calc.: 723.2).
3.2.7. (S,rac)-[(L3)Cu(OTf)]OTfÃH2OÃMeOH
(S,rac)-L3 (200 mg, 0.37 mmol) and Cu(OTf)2 (127 mg, 0.37 mmol)
in MeOH (water-free, 5 ml) were stirred under Ar at ambient tem-
perature for 6 h. The blue solution was reduced to approx. 2 ml